The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 12, 2017

Filed:

Feb. 10, 2014
Applicants:

Osaka University, Osaka, JP;

Nard Institute, Ltd., Hyogo, JP;

Inventors:

Shushi Nagamori, Osaka, JP;

Yoshikatsu Kanai, Osaka, JP;

Hidekazu Nakao, Hyogo, JP;

Tokutaro Ogata, Hyogo, JP;

Assignees:

OSAKA UNIVERSITY, Osaka, JP;

NARD INSTITUTE, LTD., Hyogo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 51/04 (2006.01); C07C 229/36 (2006.01); C07C 323/63 (2006.01); C07D 295/096 (2006.01); C07C 309/73 (2006.01);
U.S. Cl.
CPC ...
A61K 51/0402 (2013.01); C07C 229/36 (2013.01); C07C 309/73 (2013.01); C07C 323/63 (2013.01); C07D 295/096 (2013.01); C07B 2200/05 (2013.01); C07C 2101/02 (2013.01); C07C 2101/04 (2013.01); C07C 2101/08 (2013.01); C07C 2101/14 (2013.01);
Abstract

A compound having a structure represented by the general formula (I): (wherein n is 0 or 1;Rrepresents a hydrogen atom (only if n=0), a halogen atom, a C1-C6 alkyl group, a C1-C6 haloalkyl group, an optionally substituted amino group, an optionally substituted phenyl group, a C1-C6 alkylthio group, a C1-C6 alkoxy group, a C1-C6 haloalkoxy group or a C7-C12 aralkyloxy group;Rrepresents —(CH)—[O(CH)]—X (wherein X is a halogen atom, p is an integer of 1 to 6, q is an integer of 1 to 4, and r is an integer of 0 to 4);Rrepresents a hydrogen atom, a C1-C6 alkyl group, a C7-C16 aralkyl group or a C6-C14 aryl group; andRrepresents a hydrogen atom or a C1-C6 alkyl group), or a pharmaceutically acceptable salt thereof excels FAMT in terms of the tendency to accumulate intensively in cancer, the affinity for LAT1 and the selectivity for cancer, and can be labeled using an automated synthesizer in clinical settings, and therefore is useful as a highly versatile PET imaging agent.


Find Patent Forward Citations

Loading…